HeidelbergCapital and Entrepreneurs Fund lead €5m Series F for vasopharm

HeidelbergCapital Private Equity and Entrepreneurs Fund led a €5m Series F round for biopharmaceutical company vasopharm to fund the Phase III study of its lead drug candidate.